Clinical research holds the key to discovering the causes of Lung Cancer, developing effective treatment options and delivering those treatments to patients in a timely manner. What can we do to predict Lung Cancer risk, detect the disease at early onset and ultimately, prevent it? Are there novel drug combinations that can be created to pre-empt and overcome cancer cells? How can we personalize and provide targeted treatment for each individual patient? By funding clinical research, the Lung Cancer Foundation (BJALCF) hopes to find the answers to these and other critical questions.